3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
24
Breast Neoplasms
14
Neoplasms
12
Myelodysplastic Syndromes
12
Prostatic Neoplasms
10
Multiple Myeloma
8
Lung Neoplasms
7
Stomach Neoplasms
6
Sarcoma
6
Ovarian Neoplasms
5
Leukemia, Myelomonocytic, Chronic
5
Recurrence
4
Neoplasm Metastasis
4
Lymphoma, Non-Hodgkin
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumor
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Solid Tumor
3
Small Cell Lung Carcinoma
3
Pain
3
Mucositis
3
Lymphoma, T-Cell, Peripheral
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Skin Neoplasms
2
Interventions
Tissue Array Analysis
1
Standard of Care
1
Risk Factors
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Injections
1
Ferrosoferric Oxide
1
Clopidogrel
1
Aspirin
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Ischemic Stroke
×
Injections
×
Clear all
NCT05507645
2024-09-05
PUMICE
Beijing Tiantan Hospital
Phase 3
Completed
1,446 enrolled